Literature DB >> 22472343

Endolymphatic sac tumor: case report and review of the literature.

Yan-Hua Sun1, Wen Wen, Jun-Hui Wu, Jian-Ming Song, Hong Guan, Kai-Xin Wang, Mei-Quan Xu.   

Abstract

Endolymphatic sac tumor (ELST) is a rare neoplasm which can be encountered sporadically or in Von Hippel-Lindau (VHL) disease. Here we report a sporadic case of ELST in 31-year-old man. Neither the symptoms nor a family history of VHL disease were found in the patient. CT imaging demonstrated an expansile lytic lesion of the mastoid process of the left petrous bone. MR scanning revealed a 5.2 cm × 4.7 cm × 4.2 cm mass which showed hyperintensity on T1- and T2-weighted images. Histologic sections showed a papillary, cystic or glandular architecture. The papillary and glandular structures were lined by a single layer of flattened cuboidal-to-columnar cells. The stroma of the papillary fronds was richly vascularized and chronically inflamed. The tumor showed diffusely positive reactivity with cytokeratin (Pan), cytokeratin 19, cytokeratin 5/6, cytokeratin 7, EMA, vimentin, CD56, and NSE and also showed variable reactivity with glial fibrillary acidic protein (GFAP) and VEGF. The Ki-67 immunostain showed a proliferation index of < 1%. Because the mass was large, it was difficult to extirpate surgically. After surgery, the patient underwent gamma-knife radiosurgery for residual tumor. The findings indicate that ELST is a rare neoplasm with benign histopathological appearance and clinically destructive behavior. Because of the rarity of this tumor, it can easily be confused with other tumors such as paraganglioma, middle ear adenoma, adenocarcinoma, papillary carcinoma of thyroid or choroid plexus papilloma. Owing to its locally aggressive nature, it is difficult to extirpate surgically when it is large. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7973320646763012.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472343      PMCID: PMC3368761          DOI: 10.1186/1746-1596-7-36

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  20 in total

1.  Tumors of the endolymphatic sac in von Hippel-Lindau disease.

Authors:  Russell R Lonser; H Jeffrey Kim; John A Butman; Alexander O Vortmeyer; Daniel I Choo; Edward H Oldfield
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Low-grade adenocarcinoma of probable endolymphatic sac origin: CT and MR appearance.

Authors:  V T Ho; V M Rao; H T Doan; D O Mikaelian
Journal:  AJNR Am J Neuroradiol       Date:  1996-01       Impact factor: 3.825

3.  Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor.

Authors:  S Hamazaki; M Yoshida; M Yao; Y Nagashima; K Taguchi; H Nakashima; S Okada
Journal:  Hum Pathol       Date:  2001-11       Impact factor: 3.466

4.  Origin of endolymphatic sac tumor.

Authors:  Leslie Michaels
Journal:  Head Neck Pathol       Date:  2007-11-27

5.  Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience.

Authors:  Diana Bell; Paul Gidley; Nicholas Levine; Gregory N Fuller
Journal:  Ann Diagn Pathol       Date:  2010-12-16       Impact factor: 2.090

6.  [Endolymphatic sac tumor: a rare tumor of internal ear. Report of two cases].

Authors:  D Cazals-Hatem; D Henin; D Bouccara; A Rey; F Cyna-Gorse; O Sterkers; C Degott
Journal:  Ann Pathol       Date:  2000-09       Impact factor: 0.407

7.  Adenocarcinoma and adenoma of the middle ear.

Authors:  J F Pallanch; L H Weiland; T J McDonald; G W Facer; S G Harner
Journal:  Laryngoscope       Date:  1982-01       Impact factor: 3.325

8.  Endolymphatic sac tumors : report of four cases.

Authors:  Chae Wan Bae; Young Hyun Cho; Jong Woo Chung; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

9.  Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.

Authors:  A Skalova; R Síma; P Bohus; R Curík; J Lukás; M Michal
Journal:  Pathol Res Pract       Date:  2008-04-18       Impact factor: 3.250

10.  Endolymphatic sac tumor in a 4-year-old boy.

Authors:  Michael E Kupferman; Douglas C Bigelow; David F Carpentieri; Larissa T Bilaniuk; Ken Kazahaya
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

View more
  6 in total

1.  Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.

Authors:  Xiang Yang; Xue-Song Liu; Yuan Fang; Xiu-Hui Zhang; Yue-Kang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  Sporadic endolymphatic sac tumor--a diagnostic and therapeutic challenge.

Authors:  Julian Künzel; Abbas Agaimy; Joachim Hornung; Michael Lell; Oliver Ganslandt; Sabine Semrau; Johannes Zenk
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.

Authors:  B Geerts; D Leclercq; S Tezenas du Montcel; B Law-Ye; S Gerber; D Bernardeschi; D Galanaud; D Dormont; N Pyatigorskaya
Journal:  Clin Neuroradiol       Date:  2017-09-11       Impact factor: 3.649

Review 4.  Retroperitoneal composite pheochromocytoma-ganglioneuroma : a case report and review of literature.

Authors:  Jinchen Hu; Jitao Wu; Li Cai; Lei Jiang; Zhiqiang Lang; Guimei Qu; Houcai Liu; Weidong Yao; Guohua Yu
Journal:  Diagn Pathol       Date:  2013-04-15       Impact factor: 2.644

5.  Endolymphatic sac tumor at the cerebellopontine angle: A case report and review of literature.

Authors:  Afnan Alkhotani; Babar Butt; Mohammad Khalid; Mohammad Binmahfoodh; Youssef Al-Said
Journal:  Int J Surg Case Rep       Date:  2019-04-28

6.  Transcanal endoscopic assisted skull base endolymphatic sac tumor resection: A rare disease with advanced technology.

Authors:  Wai Tsz Chang; Ka Yue Tam; Hung Yao; Kwan Ho Chow; Michael Chi Fai Tong
Journal:  J Otol       Date:  2019-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.